Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Morphosys AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for MorphoSys AG

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

21 Apr 2015 Wright Reports 56 $75.00

MORPHOSYS - BACK TO PLAN A

MorphoSys and Celgene have ended their co-development alliance for MOR202. This has no immediate impact on MOR202's developme...

20 Apr 2015 Edison Investment Research 7 $10.00

Company Snapshot - Morphosys Ag

A director at Morphosys Ag bought 1,000 shares at 61.813USD and the significance rating of the trade was 64/100. Is that inf...

08 Apr 2015 Directors Deals Ltd. 1 $12.00

MORG.DE - Event Transcript of Morphosys AG conference call, Mar. 27, 2015 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, Mar. 27, 2015 / 8:00AM ET Boston, Mar 27, 2015 (Thomson StreetEvent...

27 Mar 2015 Thomson Reuters StreetEvents 13 $75.00

MorphoSys AG: Upgraded to Good

16 Mar 2015 Sadif Analytics Prime 3 $10.00

MORG.DE - Event Transcript of Morphosys AG conference call, Feb. 26, 2015 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, Feb. 26, 2015 / 8:00AM ET Boston, Feb 26, 2015 (Thomson StreetEvent...

26 Feb 2015 Thomson Reuters StreetEvents 17 $75.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) is a biotechnology company. The company...

23 Feb 2015 GlobalData 39 $125.00

Should Investors Steer Clear of the MorphoSys AG?

12 Feb 2015 Sadif Analytics Prime 12 $25.00

MORPHOSYS - DEUTSCHES EIGENKAPITALFORUM

MorphoSys has become a leading European biotech company due to its expertise in antibody production and drug development. It ...

28 Jan 2015 Edison Investment Research 2 $10.00